ArticleCancer biology & therapy2012

Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells.

Piyanuch Wonganan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.